The Latin American Brain Tumor Board Teleconference: Results of a Web-based Survey to Evaluate Participant Experience Utilizing This Resource
Overview
Authors
Affiliations
Purpose: The Latin American Brain Tumor Board (LATB) is a weekly teleconference connecting pediatric neuro-oncologists from referral centers in high-income countries with pediatric subspecialists from 20 Latin American countries since 2013. This survey explored the participants' experience utilizing this resource.
Methods: A cross-sectional electronic questionnaire was distributed to 159 participants through email and Cure4Kids.
Results: Ninety-five respondents (60%) from all the participating countries completed the survey. Sixty-one reported frequent-attendance (≥ 1 per month), 23 reported infrequent-attendance (< 1 per month), and 11 never participated. The most frequently reported attendance-barriers were the subspecialist's workload (64%), the timing of the teleconference (38%), and Internet connectivity problems (29%). Subspecialist's workload was more frequently reported as a barrier compared with other barriers, in both the frequent- and infrequent-attendance groups (p < 0.05), with the exception of the timing of the meeting in the infrequent-attendance group. More than 80% of attendees found the frequency and duration of the teleconference were sufficient. Utilizing Spanish as the primary language was reported to enhance the recommendations by 93% of the attendees. Moreover, 84% reported that the recommendations (almost) always fit the local circumstances. Furthermore, 99% of attendees found the teleconference provided a continuing medical education opportunity. Finally, 96% of attendees (almost) always found that the provided recommendations helped to improve the outcomes/quality of life of the patients.
Conclusions: The LATB teleconference provided a valuable tool for the management of pediatric brain tumors in Latin America as it provided a feasible and easy to access continued medical education opportunity for the participants.
Giron A, Blanco-Lopez J, Calderon P, Jiron R, Pineda E, Montero M Front Oncol. 2024; 14:1393454.
PMID: 39035740 PMC: 11257868. DOI: 10.3389/fonc.2024.1393454.
Abdul Rehman M, Naeem U, Rani A, Salma Shabbar Banatwala U, Salman A, Abdullah Khalid M PLoS One. 2023; 18(11):e0294635.
PMID: 37972143 PMC: 10653537. DOI: 10.1371/journal.pone.0294635.
Closing the gap: National Argentinian discussion forum on paediatric brain tumours.
Baroni L, Fernandez Ponce N, Freytes C, Maldonado F, Pinto N, Gonzalez Ramos J Front Oncol. 2023; 13:1185766.
PMID: 37274284 PMC: 10234697. DOI: 10.3389/fonc.2023.1185766.
van Huizen L, Dijkstra P, van der Werf S, Ahaus K, Roodenburg J BMJ Open. 2021; 11(12):e050139.
PMID: 34887273 PMC: 8662582. DOI: 10.1136/bmjopen-2021-050139.
Evaluation of the Pediatric Neuro-Oncology Resources Available in Chile.
Abu-Arja M, Rojas Del Rio N, Morales La Madrid A, Lassaletta A, Coven S, Moreno R JCO Glob Oncol. 2021; 7:425-434.
PMID: 33788596 PMC: 8081533. DOI: 10.1200/GO.20.00430.